• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析的经济成本:西班牙一家医疗机构中腹膜透析与中心血液透析的比较

The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.

作者信息

Rodríguez-Carmona A, Perez Fontán M, Bouza P, García Falcón T, Valdés F

机构信息

Nephrology Unit, Hospital Juan Canalejo, A Coruña, Spain.

出版信息

Adv Perit Dial. 1996;12:93-6.

PMID:8865880
Abstract

We have studied the economic cost of dialysis therapy in our area (public setting) during 1994, comparing the cost of different modalities of in-center hemodialysis (HD) and home peritoneal dialysis (PD). Analyzed costs included: personnel, drug expenditure, disposable (dialysis- and non-dialysis-related), laboratory, other services, indirect costs, maintenance and redemption, hospital admissions, transport, and home supplies. The final cost per patient and year (in 1994 US$) was: hemodiafiltration (AN69 filter, bicarbonate buffer) $58,890; HD polymethylmethacrylate filter and bicarbonate buffer $55,076; HD cuprophane and acetate buffer $49,767; CAPD $31,201; and cost of automated PD $42,519. The main expenditure sections were: home supply and hospital admissions for PD patients, and personnel, drug expenditures, disposable dialysis material, indirect costs, hospital admissions, and transport for HD patients. Home peritoneal dialysis therapy has a significantly lower economic cost than any in-center HD modality.

摘要

我们研究了1994年我们所在地区(公共机构)透析治疗的经济成本,比较了不同方式的中心血液透析(HD)和家庭腹膜透析(PD)的成本。分析的成本包括:人员、药物支出、一次性用品(与透析及非透析相关)、实验室、其他服务、间接成本、维护与赎回、住院、交通和家庭用品。每位患者每年的最终成本(以1994年美元计)为:血液滤过(AN69滤器,碳酸氢盐缓冲液)58,890美元;HD聚甲基丙烯酸甲酯滤器和碳酸氢盐缓冲液55,076美元;HD铜仿膜和醋酸盐缓冲液49,767美元;持续性非卧床腹膜透析(CAPD)31,201美元;自动化腹膜透析成本42,519美元。主要支出部分为:PD患者的家庭用品和住院费用,以及HD患者的人员、药物支出、一次性透析材料、间接成本、住院和交通费用。家庭腹膜透析治疗的经济成本明显低于任何中心HD方式。

相似文献

1
The economic cost of dialysis: a comparison between peritoneal dialysis and in-center hemodialysis in a Spanish unit.透析的经济成本:西班牙一家医疗机构中腹膜透析与中心血液透析的比较
Adv Perit Dial. 1996;12:93-6.
2
[Costs of chronic dialysis in a public hospital: myths and realities].[公立医院慢性透析的成本:误区与现实]
Nefrologia. 2001 May-Jun;21(3):283-94.
3
Cost analysis of dialysis treatments for end-stage renal disease (ESRD).终末期肾病(ESRD)透析治疗的成本分析。
Clin Invest Med. 1995 Dec;18(6):455-64.
4
Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements.血液透析和腹膜透析外包协议的成本和附加值。
Nefrologia. 2011;31(6):656-63. doi: 10.3265/Nefrologia.pre2011.Oct.11032.
5
Comparative study of costs and quality of life of chronic ambulatory peritoneal dialysis and hemodialysis patients in Israel.以色列慢性非卧床腹膜透析和血液透析患者的成本与生活质量比较研究。
Isr J Med Sci. 1985 Apr;21(4):335-9.
6
Cost effectiveness evaluation of the Ministry of Health Malaysia dialysis programme.马来西亚卫生部透析项目的成本效益评估。
Med J Malaysia. 1999 Dec;54(4):442-52.
7
[Self dialysis: a new method of treatment for end-stage renal disease].[自我透析:终末期肾病的一种新治疗方法]
Nephrologie. 1984;5(3):115-8.
8
Combined peritoneal dialysis and hemodialysis therapy improves quality of life in end-stage renal disease patients.腹膜透析和血液透析联合治疗可改善终末期肾病患者的生活质量。
Adv Perit Dial. 2000;16:108-12.
9
Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.终末期肾病患者腹膜透析与血液透析的成本比较
Am J Manag Care. 2009 Aug;15(8):509-18.
10
Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.马来西亚卫生部医院中心血液透析与持续性非卧床腹膜透析的经济学评估
Nephrology (Carlton). 2005 Feb;10(1):25-32. doi: 10.1111/j.1440-1797.2005.00360.x.

引用本文的文献

1
Is the cost of the new home dialysis techniques still advantageous compared to in-center hemodialysis? An Italian single center analysis and comparison with experiences from western countries.与中心血液透析相比,新型家庭透析技术的成本是否仍然具有优势?一项意大利单中心分析及与西方国家经验的比较。
Front Med (Lausanne). 2024 Mar 11;11:1345506. doi: 10.3389/fmed.2024.1345506. eCollection 2024.
2
Willingness to participate in a randomized trial comparing catheters to fistulas for vascular access in incident hemodialysis patients: an international survey of nephrologists.新确诊血液透析患者血管通路中导管与动静脉内瘘比较的随机试验参与意愿:肾脏病学家的国际调查
Can J Kidney Health Dis. 2016 Jul 13;3:33. doi: 10.1186/s40697-016-0125-6. eCollection 2016.
3
Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.将成人对成人活体肝移植纳入肝移植项目可提高生存率,但成本会增加。
Liver Transpl. 2009 Feb;15(2):148-62. doi: 10.1002/lt.21671.
4
Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.罗格列酮联合二甲双胍治疗西班牙2型糖尿病的终生健康后果及成本效益
Pharmacoeconomics. 2006;24 Suppl 1:49-59. doi: 10.2165/00019053-200624001-00005.